These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30297248)

  • 1. Appropriateness of ordering serum angiotensin-converting enzyme during renin-angiotensin-aldosterone system inhibitor therapy.
    Betrains A; Vermeersch P; Vanderschueren S
    Eur J Intern Med; 2019 Jan; 59():e18-e19. PubMed ID: 30297248
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing angiotensin-converting enzyme (ACE) protein is more appropriate than ACE activity when investigating sarcoidosis.
    Pretorius CJ; Ungerer JP
    Med J Aust; 2020 Aug; 213(4):178-179. PubMed ID: 32442339
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute effects of captopril on serum angiotensin-converting enzyme activity, the renin-aldosterone system and blood pressure in patients with sarcoidosis.
    Mizuno K; Gotoh M; Matsui J; Nagasawa S; Fukuchi S
    Tohoku J Exp Med; 1983 May; 140(1):107-8. PubMed ID: 6306866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variations in plasma angiotensin-converting enzyme and renin in sarcoidosis].
    Hâulică I; Ionescu C; Mihăescu T; Roşca V; Rusu V; Tănase-Galicescu C; Stratone A; Boişteanu D
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):155-9. PubMed ID: 2554455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and renin-angiotensin-aldosterone system: believe it or not.
    Fauchier L; de Groote P
    Europace; 2011 Mar; 13(3):297-8. PubMed ID: 21217131
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors in the treatment of sarcoidosis and association with ACE gene polymorphism: case series.
    Kaura V; Kaura NV; Kaura BN; Kaura CS
    Indian J Chest Dis Allied Sci; 2013; 55(2):105-7. PubMed ID: 24047001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymes in sarcoidosis. Angiotensin-converting-enzyme (ACE).
    Lieberman J
    Clin Lab Med; 1989 Dec; 9(4):745-55. PubMed ID: 2556234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic fibrosis and the renin-angiotensin system.
    Abbas G; Silveira MG; Lindor KD
    Am J Ther; 2011 Nov; 18(6):e202-8. PubMed ID: 20535005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of serial measurement of serum angiotensin converting enzyme in the management of sarcoidosis.
    Rohatgi PK; Ryan JW; Lindeman P
    Am J Med; 1981 Jan; 70(1):44-50. PubMed ID: 6257112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and lymph-node collagenase in sarcoidosis. Comparison with angiotensin-converting enzyme.
    Silverstein E; Lockerman Z; Friedland J
    Am J Clin Pathol; 1978 Sep; 70(3):348-51. PubMed ID: 212944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme and its clinical significance--a review.
    Studdy PR; Lapworth R; Bird R
    J Clin Pathol; 1983 Aug; 36(8):938-47. PubMed ID: 6308066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update of the blockade of the renin angiotensin aldosterone system in clinical practice.
    Márquez DF; Ruiz-Hurtado G; Ruilope LM; Segura J
    Expert Opin Pharmacother; 2015; 16(15):2283-92. PubMed ID: 26389772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin-aldosterone system inhibitors in heart failure.
    Shearer F; Lang CC; Struthers AD
    Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiotensin-converting enzyme activity as an indicator of prognosis in sarcoidosis.
    Ueda E; Kawabe T; Tachibana T; Kokubu T
    Am Rev Respir Dis; 1980 Apr; 121(4):667-71. PubMed ID: 6247943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme in sarcoid perivasculitis.
    Willis DA; Unger KM; Tang RA
    Ann Ophthalmol; 1983 Aug; 15(8):778-81. PubMed ID: 6318638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme activity and steroid therapy in sarcoidosis.
    Umeki S; Niki Y; Soejima R
    Arch Intern Med; 1987 Nov; 147(11):2056. PubMed ID: 2823736
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis.
    Marshall BG; Shaw RJ
    Thorax; 1998 Jun; 53(6):439-40. PubMed ID: 9713438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.